Analysis reveals high healthcare costs in hypoparathyroidism patients, suggesting the need for tailored therapies.
Hypoparathyroidism, due to its chronicity and complex comorbidity profile, represents a substantial and long-term source of healthcare expenditure. These findings highlight an unmet need, particularly for patients at higher treatment intensity, requiring more specific therapies to improve outcomes.
No takes yet. Share an insight, caveat, or question.
Palermo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: